Inmar and Other Pharmaceutical Experts Lead Rx Waste Management and Reverse Logistics Panel Discussion

Share Article

Inmar Regulatory Counsel Richard Sieg a panelist at HDMA Distribution Management Conference

News Image

Inmar Regulatory Counsel and former government environmental inspector and regulatory attorney Richard Sieg will join a panel of industry professionals to discuss financial and operational implications the pharmaceutical industry must manage as they comply with new regulations proposed by the U.S. Environmental Protection Agency (EPA). The session, Implications and Perspectives on Managing Waste and Reverse Logistics, will be conducted at the HDMA Distribution Management Conference on March 8, 2016 in San Antonio, Texas.

In September 2015, the EPA published a proposed rule intended to revise its regulations to improve the management and disposal of hazardous waste pharmaceuticals. The agency’s intention is to create a tailored, sector-specific set of regulations for the management of hazardous waste pharmaceuticals by healthcare facilities (including pharmacies) and reverse distributors. The aim of the proposed rule is to provide standards to ensure the management of hazardous waste pharmaceuticals is safe and workable, and that the rules reflect realistic handling and disposition expectations within the healthcare setting. Earlier rules were based on regulations originally written for industrial settings, presenting challenges in translation to healthcare.

Sieg brings his experience as a to the panel. Joining him on the panel are Jim Cline, Director, Environmental Health and Safety, Cardinal Health, Inc. and Sue Pifer, Vice President, Compliance, Retail Industry Leaders Association.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sharon Joyner-Payne
Inmar, Inc.
+1 (336) 631-7663
Email >
Visit website